We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$15B
AUM Growth
+$614M
Cap. Flow
-$689M
Cap. Flow %
-4.6%
Top 10 Hldgs %
9.86%
Holding
499
New
33
Increased
63
Reduced
287
Closed
34

Top Sells

Rank Stock Value
1
PODD icon
Insulet
PODD
+$86.4M
2
SAGE
Sage Therapeutics
SAGE
+$56.2M
3
WEC icon
WEC Energy
WEC
+$49.5M
4
AOS icon
A.O. Smith
AOS
+$48.9M
5
CHRW icon
C.H. Robinson
CHRW
+$41.8M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Healthcare 17.37%
3 Industrials 15.16%
4 Consumer Discretionary 13.51%
5 Financials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOH icon
326
Molina Healthcare
MOH
$10.2B
$9.99M 0.07%
73,658
-12,600
-15% -$1.59M
ON icon
327
ON Semiconductor
ON
$31.8B
$9.95M 0.07%
+408,125
New +$8.62M
LW icon
328
Lamb Weston
LW
$7.22B
$9.94M 0.07%
+115,550
New +$9.31M
DEO icon
329
Diageo
DEO
$49B
$9.82M 0.07%
58,315
-2,271
-4% -$369K
PAYX icon
330
Paychex
PAYX
$41.6B
$9.68M 0.06%
113,850
-12,350
-10% -$1.04M
WLK icon
331
Westlake Corp
WLK
$9.03B
$9.53M 0.06%
135,775
-18,250
-12% -$1.23M
KNSL icon
332
Kinsale Capital Group
KNSL
$8.12B
$9.45M 0.06%
+92,965
New +$9.25M
AMGN icon
333
Amgen
AMGN
$208B
$9.45M 0.06%
39,200
-2,900
-7% -$639K
JBLU icon
334
JetBlue
JBLU
$2.28B
$9.37M 0.06%
500,325
-40,600
-8% -$754K
S
335
DELISTED
Sprint Corporation
S
$9.3M 0.06%
1,785,599
-18,600
-1% -$109K
SAM icon
336
Boston Beer
SAM
$1.91B
$9.29M 0.06%
24,591
-5,260
-18% -$1.98M
NEM icon
337
Newmont
NEM
$98.7B
$9.24M 0.06%
212,775
-41,625
-16% -$1.63M
KNX icon
338
Knight Transportation
KNX
$11.3B
$9.15M 0.06%
255,400
-89,400
-26% -$3.28M
TSCO icon
339
Tractor Supply
TSCO
$16.1B
$9.14M 0.06%
489,000
-249,000
-34% -$4.72M
PYPL icon
340
PayPal
PYPL
$48.9B
$9.08M 0.06%
83,900
-6,000
-7% -$625K
SAP icon
341
SAP
SAP
$212B
$9.02M 0.06%
67,313
-2,621
-4% -$344K
ADBE icon
342
Adobe
ADBE
$99.5B
$8.81M 0.06%
26,700
-12,200
-31% -$3.59M
TMO icon
343
Thermo Fisher Scientific
TMO
$213B
$8.77M 0.06%
27,000
-1,900
-7% -$576K
TFC icon
344
Truist Financial
TFC
$63.3B
$8.7M 0.06%
+154,542
New +$8.37M
TREE icon
345
LendingTree
TREE
$447M
$8.67M 0.06%
28,563
-61,900
-68% -$20.5M
ORLY icon
346
O'Reilly Automotive
ORLY
$72.9B
$8.6M 0.06%
294,375
-35,625
-11% -$1.02M
ENB icon
347
Enbridge
ENB
$119B
$8.54M 0.06%
214,706
-8,341
-4% -$312K
FISV
348
Fiserv Inc
FISV
$28.8B
$8.39M 0.06%
72,600
-5,100
-7% -$563K
NVS icon
349
Novartis
NVS
$297B
$8.39M 0.06%
88,648
-3,444
-4% -$309K
ARQL
350
DELISTED
Arqule Inc
ARQL
$8.35M 0.06%
418,162
-1,978,773
-83% -$22.9M

Similar funds

Carillon Tower Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Carillon Tower Advisers held 499 positions worth $15B, up 4.3% from $14.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Carillon Tower Advisers withdrew a net $689M in Q4 2019, closing 34 positions and reducing 287 holdings. Its most notable exit was Insulet, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in Seagen Inc. Common Stock worth $48.8M.

  • Carillon Tower Advisers's largest Q4 2019 buy was Seagen Inc. Common Stock: 426,867 shares worth $48.8M.
  • Carillon Tower Advisers added most to Corpay in Q4 2019, an estimated $58.8M increase.
  • Carillon Tower Advisers's biggest Q4 2019 reduction was WEC Energy, cutting an estimated $49.5M.
  • Carillon Tower Advisers fully exited Insulet in Q4 2019, selling an estimated $86.4M.
  • Carillon Tower Advisers's ten largest holdings make up 9.9% of its $15B portfolio in Q4 2019.
  • Carillon Tower Advisers opened 33 new positions and closed 34 in Q4 2019.
  • Carillon Tower Advisers's portfolio value rose 4.3% quarter-over-quarter to $15B.

Based on Carillon Tower Advisers's 13F filing for Q4 2019, filed 11 Feb 2020.